News | Congenital Heart | January 14, 2016

Embryonic Heart Valve Research May Prevent Newborn Congenital Heart Defects

Cornell researchers discover enzymes that play key role in formation of heart valves

heart valve formation, newborns, congenital heart defects, Cornell study

January 14, 2016 — Cornell biomedical engineers have discovered natural triggers that could reduce the chance of life-threatening, congenital heart defects among newborn infants. Those triggers can override developmental, biological miscues, leading to proper embryonic heart and valve formation.

More than 40,000 babies in the United States – or about 1 in 100 births – are born annually with a congenital heart defect, making it the most common defect, according to the Children’s Heart Foundation.

“The heart is the first organ to form in the embryo. It morphs dynamically and rapidly all the while pumping nutrients to the developing body,” said senior author Jonathan Butcher, associate professor at Cornell’s Nancy E. and Peter C. Meinig School of Biomedical Engineering.

The early embryonic heart originates as a looped tube, without valves or pumping chambers. During the last few weeks of the first trimester, these heart chambers form, but need something to maintain one-way blood flow.

“Wispy globular masses (called cushions because of their shape in the heart wall) need to condense and elongate to form thin robust leaflets capable of fast and resilient opening and closing,” Butcher said. “It is this maturation process that’s likely disrupted in many clinical cases.”

Until this study, scientists did not know how – or if – mechanical forces drove the biological remodeling of cushions into valves. Medical science understood that the embryonic heart needed blood flow to grow, but the valve component’s role was not entirely understood, Butcher said.

The researchers found that cyclic stretches and stressing forces activate sensitive enzymes called GTPases, specifically RhoA and Rac1, which coordinate the embryonic heart’s maturation. Without the enzymes activating at the proper times, heart valves do not form correctly.

“We identified a mechanism that transduced – or translated – a mechanical force into a biological response,” Butcher said. “That biological response over time creates these thin, flexible, formative leaflets. If this tissue fails to get thinner, that’s a problem. If the tissue fails to elongate, that’s a problem. And these are all problems we see in the clinic.”

This work lays a foundation for hemodynamically informed surgical interventions to potentially retard valve malformation – or to restore it, Butcher said.

The research, which is published in Current Biology, was supported by the National Science Foundation, the National Institutes of Health and the American Heart Association.

For more information: www.bme.cornell.edu

Related Content

Plant-Based Diets Benefit Athletes' Heart Health, Endurance, Recovery
News | Cardiac Diagnostics | January 21, 2019
Meat-free athletes have already proven the performance-boosting power of a plant-based diet. Now, “Plant-Based Diets...
Sedentary Lifestyle Cancels Out Heart Benefits of Normal Weight
News | Cardiac Diagnostics | January 09, 2019
January 9, 2019 — Researchers at the University of Florida have found that low levels of physical activity can put he
Livongo Launches Applied Health Signals Product Category
News | Cardiac Diagnostics | November 30, 2018
Healthcare technology company Livongo recently announced the launch of its Applied Health Signals product category,...
HHS Releases Second Edition of Physical Activity Guidelines for Americans. #AHA2018 #AHA18
News | Cardiac Diagnostics | November 14, 2018
The U.S. Department of Health and Human Services (HHS) released the second edition of the Physical Activity Guidelines...
ACC and AHA Release Updated Cholesterol Guidelines for 2018. #AHA18 #AHA2018
Feature | Cardiac Diagnostics | November 13, 2018
November 13, 2018 — New cholesterol guidelines from the American Heart Association (AHA) and the American College of
AMI READMITS Score Predicts Heart Attack Patients at High Readmission Risk
News | Cardiac Diagnostics | October 09, 2018
Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those...
Siemens Healthineers Showcases New In Vivo and In Vitro Cardiovascular Solutions at TCT 2018
News | Cardiac Diagnostics | September 21, 2018
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego, Siemens Healthineers...
Weight Loss Drug Does Not Increase Cardiovascular Events
News | Cardiac Diagnostics | August 31, 2018
A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI...
Acarix Presents CADScor System at ESC 2018
News | Cardiac Diagnostics | August 27, 2018
Acarix AB’s ultra-sensitive acoustic CADScor System for coronary artery disease risk assessment will be on display at...
NIH Ending Funding for Moderate Alcohol and Cardiovascular Health Trial
News | Cardiac Diagnostics | August 24, 2018
The National Institutes of Health announced in June it plans to end funding to the Moderate Alcohol and Cardiovascular...
Overlay Init